![[Internal] Sling Therapeutics Phase 2b3 Thyroid eye disease](https://piemagazine.org/wp-content/uploads/sites/4/2025/01/Internal-Sling-Therapeutics-Phase-2b3-Thyroid-eye-disease-1182x540.png)
Sling Therapeutics Reports Positive Results in Phase IIb/III Thyroid Eye Disease Candidate
The company’s first-in-class oral small molecule linsitinib met its primary endpoint, showing statistically significant proptosis reduction with a favorable safety…
The company’s first-in-class oral small molecule linsitinib met its primary endpoint, showing statistically significant proptosis reduction with a favorable safety…
![[Topcon] 2024 Recap Thumbnail Topcon Healthcare 2024 Recap (1)](https://piemagazine.org/wp-content/uploads/sites/4/2025/01/Topcon-2024-Recap-Thumbnail-Topcon-Healthcare-2024-Recap-1-579x326.png)
![[Internal] Newsroom Researchers Develop Head Mounted Robotic System for Retinal Surgery (1)](https://piemagazine.org/wp-content/uploads/sites/4/2025/02/Internal-Newsroom-Researchers-Develop-Head-Mounted-Robotic-System-for-Retinal-Surgery-1-579x326.png)
